Press releases | Finance | 16 Mar 2018

Travers Smith advises Peel Hunt and WG Partners on £20.5 million capital raising by Oxford BioMedica plc

Overview

Travers Smith LLP has advised Peel Hunt LLP and WG Partnership LLP, as joint bookrunners in connection with the £20.5 million placing of new shares by Oxford BioMedica plc.

Oxford BioMedica is a leading gene and cell therapy company focused in developing life changing treatment for serious diseases.

The Travers Smith team comprised Corporate Finance Partners Neal Watson and Dan McNamee, Corporate Finance Senior Associates Tom Coulter and Brent Sanders, and Corporate Finance Associate Stephanie Poulier

Oxford BioMedica was represented by Covington & Burling LLP.